Get started
Author

Christopher Fiore

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
2009 · Qianben Wang, Wei Li, et al. · Cell · 918
PDF
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
2009 · Toshiro Migita, Stacey Ruiz, et al. · JNCI Journal of the National Cancer Institute · 395
PDF
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
2013 · Changmeng Cai, Hongyun Wang, et al. · Journal of Clinical Investigation · 273
High-throughput functional testing of ENCODE segmentation predictions
2014 · Jamie C. Kwasnieski, Christopher Fiore, et al. · Genome Research · 225
PDF
Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy
2019 · Marie-Eve Beaulieu, Toni Jauset, et al. · Science Translational Medicine · 214
Vitamin D Receptor Protein Expression in Tumor Tissue and Prostate Cancer Progression
2011 · Whitney K. Hendrickson, Richard Flavin, et al. · Journal of Clinical Oncology · 149
PDF
Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer
2008 · Michelangelo Fiorentino, Giorgia Zadra, et al. · Laboratory Investigation · 136
Fatty Acid Synthase Polymorphisms, Tumor Expression, Body Mass Index, Prostate Cancer Risk, and Survival
2010 · Paul L. Nguyen, Jing Ma, et al. · Journal of Clinical Oncology · 132
PDF
c‐Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme
2009 · Eric L Snyder, Deborah J Sandstrom, et al. · The Journal of Pathology · 90
PDF
Functional cis-regulatory modules encoded by mouse-specific endogenous retrovirus
2017 · Vasavi Sundaram, Mayank N. K. Choudhary, et al. · Nature Communications · 89
PDF
SPINK1 Protein Expression and Prostate Cancer Progression
2014 · Richard Flavin, Andreas Pettersson, et al. · Clinical Cancer Research · 76
Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry
2012 · Christopher Fiore, Dyane Bailey, et al. · Journal of Clinical Pathology · 62
PDF
Interactions between pluripotency factors specifycis-regulation in embryonic stem cells
2016 · Chris Fiore, Barak A. Cohen · Genome Research · 51
PDF
Immunohistochemical Expression of BRCA1 and Lethal Prostate Cancer
2010 · Michelangelo Fiorentino, Gregory Judson, et al. · Cancer Research · 50
PDF
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
2022 · Stéphane de Botton, Thomas Cluzeau, et al. · Blood Advances · 41
PDF
Model-based transcriptome engineering promotes a fermentative transcriptional state in yeast
2016 · Drew G. Michael, Ezekiel J. Maier, et al. · Proceedings of the National Academy of Sciences · 37
ΔNp63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells
2022 · Arthur W. Lambert, Christopher Fiore, et al. · Developmental Cell · 35
PDF
Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia
2018 · Michael R. McKeown, Liv Johannessen, et al. · Haematologica · 18
PDF
Erythroid lineage chromatin accessibility maps facilitate identification and validation of NFIX as a fetal hemoglobin repressor
2023 · Mudit Chaand, Chris Fiore, et al. · Communications Biology · 10
PDF
Selection of RARA-Positive Newly Diagnosed Unfit AML Patients with Elevated RARA Gene Expression Enriches for Features Associated with Primary Resistance to Venetoclax and Clinical Response to SY-1425, a Potent and Selective RARα Agonist, Plus Azacitidine
2020 · Christopher Fiore, Michael J. Kelly, et al. · Blood · 2
SY1425 (tamibarotene) Induces Profound Transcriptional Changes in AML Tumors with High Retinoic Acid Receptor Alpha
2016 · Christopher Fiore, Michael R McKeown, et al. · Blood · 1
Abstract P4-04-02: Epigenomic analysis of cancer stem cells (CSCs) from triple-negative breast cancer (TNBC) reveals p63 and p73 as core metastasis drivers
2020 · Arthur Lambert, Christopher Fiore, et al. · Cancer Research
Abstract 3956: Omomyc-based cell-penetrating peptides: From proof of concept to a clinically viable anti-Myc therapy
2018 · Marie-Eve Beaulieu, Toni Jauset, et al. · Cancer Research
Abstract PR05: SY-1425 (tamibarotene), a potent and selective RARα agonist, induces changes in the transcriptional regulatory circuit of AML cells leading to differentiation
2017 · Christopher M. Fiore, Michael R. McKeown, et al. · Clinical Cancer Research
Abstract 2167: Preclinical validation of an Omomyc cell-penetrating peptide as a viable anti-Myc therapy
2017 · Marie-eve Beaulieu, Toni Jauset, et al. · Cancer Research
Works count: 29
Citation count: 3,004
H-index: 18
I10-index: 19
Year
Topic
Type